Bradley L. Campbell - President and CEO, Director at Amicus Therapeutics, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
President and CEO, Director
Stock Symbol
FOLD on Nasdaq
All Insider Reports
All Insider Reports

Bradley L. Campbell - trading volume in the past year for Amicus Therapeutics, Inc.

Holdings reported by Bradley L. Campbell for Amicus Therapeutics, Inc.

Class Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock 887K $10.4M $11.71 Sep 3, 2024 Direct
Stock Options (right to buy) 37.5K Jul 5, 2024 Direct Common Stock
Stock Options (right to buy) 22.5K Sep 3, 2024 Direct Common Stock

Transactions reported by Bradley L. Campbell for Amicus Therapeutics, Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.